SIRONA BIOCHEM WKN: A0RM6R ISIN: CA82967M1005 Kürzel: ZSB Forum: Aktien Thema: Hauptdiskussion

Und das ist das große Problem!!

Sehr ernüchternd die Aussagen von Chris. Sirona wird leider immer noch nicht wahr- bzw. ernstgenommen. Die AA Studie war wohl nicht ausreichend.

Bin jedenfalls sehr froh, dass die 2 teilzeittrottel verstanden haben, dass sie Hilfe von außen annehmen müssen um die Bude unter den Hammer zu bekommen.

Bitte abbvie erkenne den Wert von aa und kauf endlich den Laden damit wir alle zufrieden die Nerven schonen können und die Amateur nicht noch Jahre weiter Blödsinn machen

Klasse der Chris. Führt das bla bla von Michelle munter weiter

Den letzten Satz finde ich interessant 😃 😉

Hi, I intended to convey that the enterprises we are engaged with are quite extensive, thus requiring some time to navigate their organizational structure in order to reach the individuals responsible for making decisions. Our introduction through Bio was a fantastic initial step towards our collaborative endeavors, yet we haven't halted our progress there. We are actively exploring numerous methods to engage with potential partners, utilizing all feasible channels within our resource constraints. Atheln remains committed to providing assistance. We hold the belief that the company's valuation doesn't adequately reflect its worth, considering the array of compounds in our portfolio and the distinctive scientific proficiency we hold.

Klingt aber irgendwie noch nicht so, dass die ‚richtigen‘ Leute ihr Interesse an AA bereits bekundet haben bzw. was am Anlaufen ist. Na mal sehen wie es weiter geht..

Und noch einer hinterher. Schauen wir Mal wie es weitergeht!!

Thanks Peter, the summer has been very quiet indeed. Its been a struggle to get through to the decision makers over the last few weeks for sure. We are working on a few initiatives that will generate increased attention to the portfolio, especially our anti-aging compound which we believe will be a major success as soon as the right people realize what we have. Agreed, with respect to shareholder communication. We can definitely do better and we will do better.   Your support is very much appreciated.   Cheers/ Chris

Sie kannte ja das Potenzial aus erster hand. Also nein...

Hi Peter, thanks for your email. Michelle has decided to pursue new opportunities. The departure is amicable and she is aiding in the transition process. Simultaneously, the company is enacting various measures to facilitate a seamless transition. This includes adding more support resources and making adjustments to roles in both the France and Canada offices.   Going forward, feel free to reach out to me directly and I will endeavor to expedite a response (as I have done today).   Thanks! Chris

Hatte michelle auch viele shares?

Klingt ja euphorisch

grins

Viel Glück… na toll 🙈